EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY-NC 4.0

Association of Protocol Design‐Related Factors With Enrollment Duration in Clinical Trials

Hiroaki Tsuchiya iD, Miwa Sekine iD, Yuji Nishizaki iD, Noriko Hida iD, Takehiko Sambe iD, Shoji Sanada iD, Toshio Naito iD

Clinical and Translational Science · 2026-04 · 19 (4)

DOI: 10.1111/cts.70529 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Clinical and Translational Science, online erschienen am 22.03.2026. Verfasst von Hiroaki Tsuchiya und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Clinical Trials, Phase III as Topic, COVID-19, Patient Selection, Research Design. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patient enrollment is a critical factor in the success of clinical trials; however, many trials fail to recruit participants within a planned timeline. Protocol design is a key barrier to efficient recruitment. However, few studies have quantitatively evaluated the association between protocol design and enrollment duration across various disease areas and time periods. We conducted a cross‐sectional study using data from ClinicalTrials.gov and another related database. Industry‐sponsored phase 2 and 3 drug trials completed between January 2017 and September 2024 were included. Key variables related to the protocol design were extracted from trial protocols and database entries. The enrollment duration was estimated using the trial start dates, primary completion dates, and outcome time frames. Multiple linear regression analyses were conducted to identify factors associated with enrollment duration, including comparisons between the pre‐ and post‐COVID‐19 pandemic periods. In total, 1286 trials met the inclusion criteria. Multiple linear regression identified three variables significantly associated with a longer enrollment duration: number of original enrollments ( p = 0.023), number of inclusion criteria ( p < 0.001), and days of assessment ( p = 0.013). Before the pandemic, the number of assessment days was the primary factor, while after the pandemic, the number of inclusion criteria had the strongest association. This study demonstrated that the enrollment duration was significantly influenced by protocol design features. To improve recruitment efficiency, careful consideration of the inclusion criteria, assessment burden, and enrollment targets is essential during trial planning. Causal relationships should be interpreted cautiously and further examined in future research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials, Phase III as TopicCOVID-19Patient SelectionResearch DesignHumansClinical Trials, Phase II as TopicCross-Sectional StudiesDatabases, FactualLinear ModelsTime Factors

Stichwörter der Autor:innen

clinical trialsdata analysisdrug developmentphase IIphase III

Autor:innen und Institutionen

  • Department of General Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Division of Medical Education, Juntendo University Faculty of Medicine, Tokyo, Japan.
  • Department of General Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.
  • Department of Clinical Research and Development, Graduate School of Pharmacy, SHOWA Medical University, Tokyo, Japan.
  • Research Administration Center, SHOWA Medical University, Tokyo, Japan.
  • Clinical and Translational Research Center, Kobe University Hospital, Kobe, Hyogo, Japan.

ORCID-Profile: Hiroaki Tsuchiya, Miwa Sekine, Yuji Nishizaki, Noriko Hida, Takehiko Sambe, Shoji Sanada, Toshio Naito

Zitieren

APA

Tsuchiya, H., Sekine, M., Nishizaki, Y., Hida, N., Sambe, T., Sanada, S., & Naito, T. (2026). Association of Protocol Design‐Related Factors With Enrollment Duration in Clinical Trials. Clinical and Translational Science, 19(4). https://doi.org/10.1111/cts.70529

Vancouver

Tsuchiya H, Sekine M, Nishizaki Y, Hida N, Sambe T, Sanada S, et al. Association of Protocol Design‐Related Factors With Enrollment Duration in Clinical Trials. Clinical and Translational Science. 2026;19(4). doi:10.1111/cts.70529

BibTeX
@article{Tsuchiya2026,
  author = {Tsuchiya, Hiroaki and Sekine, Miwa and Nishizaki, Yuji and Hida, Noriko and Sambe, Takehiko and Sanada, Shoji and Naito, Toshio},
  title = {Association of Protocol Design‐Related Factors With Enrollment Duration in Clinical Trials},
  journal = {Clinical and Translational Science},
  year = {2026},
  volume = {19},
  number = {4},
  doi = {10.1111/cts.70529}
}
Kostenlos starten →